资讯|论坛|病例

搜索

首页 医学论坛 专业文章 医学进展 签约作者 病例中心 快问诊所 爱医培训 医学考试 在线题库 医学会议

您所在的位置:首页 > 内分泌科诊疗指南 > 2014欧洲低钠血症诊断和治疗临床实践指南

2014欧洲低钠血症诊断和治疗临床实践指南

2014-05-27 16:31 阅读:2271 来源:爱爱医 作者:爱爱医 责任编辑:爱爱医
[导读] 《2014欧洲低钠血症诊断和治疗临床实践指南》内容简介 Hyponatraemia, defined as a serum sodium concentration!135 mmol/l, is the most common disorder of body fluid andelectrolyte balance encountered in clinical practice. It can lead to a wide

    《2014欧洲低钠血症诊断和治疗临床实践指南》内容简介

Hyponatraemia, defined as a serum sodium concentration!135 mmol/l, is the most common disorder of body fluid andelectrolyte balance encountered in clinical practice. It can lead to a wide spectrum of clinical symptoms, from subtle to severeor even life threatening, and is associated with increased mortality, morbidity and length of hospital stay in patientspresenting with a range of conditions. Despite this, the management of patients remains problematic. The prevalence ofhyponatraemia in widely different conditions and the fact that hyponatraemia is managed by clinicians with a broad varietyof backgrounds have fostered diverse institution- and speciality-based approaches to diagnosis and treatment. To obtain acommon and holistic view, the European Society of Intensive Care Medicine (ESICM), the European Society of Endocrinology(ESE) and the European Renal Association – European Dialysis and Transplant Association (ERA–EDTA), represented byEuropean Renal Best Practice (ERBP), have developed the Clinical Practice Guideline on the diagnostic approach andtreatment of hyponatraemia as a joint venture of three societies representing specialists with a natural interest inhyponatraemia. In addition to a rigorous approach to methodology and evaluation, we were keen to ensure that thedocument focused on patient-important outcomes and included utility for clinicians involved in everyday practice

    《2014欧洲低钠血症诊断和治疗临床实践指南》内容预览

    4. Methods for guideline development

    4.1. Establishment of the guideline developmentgroupThe councils of the three participating societies, ESICM,ESE and ERBP, selected the co-chairs of the guidelinedevelopment group. The co-chairs then assembled thesteering committee with representatives of the threesocieties involved in this joint venture. This steeringcommittee convened in October 2010 and decided on thecomposition of the guideline development group, takinginto account the clinical and research expertise of theproposed candidates. The guideline development groupconsisted of content experts, which included individualswith expertise in hyponatraemia, endocrinology, generalinternal medicine, intensive care medicine and clinicalnephrology as well as an expert in systematic reviewmethodology. The ERBP methods support team providedmethodological input and practical assistance throughoutthe guideline development process.

    4.2. Developing clinical questionsFrom the final scope of the guideline, specific researchquestions, for which a systematic review would beconducted, were identified.

    4.2.1. Diagnosis and differential diagnosis of hypotonichyponatraemia

    1. In patients with hypotonic hyponatraemia, howaccurate are various 'diagnostic strategies' in comparisonwith a reference test of infusing 2 l 0.9% sodiumchloride solution for differentiating hypovolaemic fromeuvolaemic hyponatraemia?

    点击下载***
《2014欧洲低钠血症诊断和治疗临床实践指南》


分享到:
  版权声明:

  本站所注明来源为"爱爱医"的文章,版权归作者与本站共同所有,非经授权不得转载。

  本站所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们

  联系zhoumeifang@120.net,我们将立即进行删除处理

意见反馈 关于我们 隐私保护 版权声明 友情链接 联系我们

Copyright 2002-2021 Iiyi.Com All Rights Reserved